Tag: COVID-19 drug trial: three-drug combo may treat mild-to-moderate cases

COVID-19 drug trial: three-drug combo may treat mild-to-moderate cases

May 13, 2020

A combination of three antiviral drugs — interferon beta-1b, lopinavir-ritonavir, and ribavirin – and standard care has been found to shorten the duration of viral shedding associated with COVID-19. This relates to the dangerous period when the virus is detectable in a person’s body and potentially transmissible to others. Researchers at the University of Hong […]

Continue Reading